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• Goiter refers to an enlarged thyroid gland… 
due to by different mechanisms :
 Biosynthetic defects, 
 Iodine deficiency, 
 autoimmune disease, 
 nodular diseases
• Graves’ disease and Hashimoto’s thyroiditis 
are also associated with goiter…
• When diffuse enlargement of the thyroid occurs in the absence of nodules and 
hyperthyroidism, it is referred to as a diffuse nontoxic goiter. 
• Worldwide, diffuse goiter is most commonly caused by iodine deficiency and is 
termed endemic goiter when it affects >5% of the population. 
DIFFUSE NONTOXIC (SIMPLE) GOITER
• Endemic goiter is also caused by exposure to environmental goitrogens such as 
cassava root, which contains a thiocyanate; vegetables of the Cruciferae family
(known as cruciferous vegetables) and milk from regions where goitrogens are 
present in grass…
• Although relatively rare, inherited defects in thyroid hormone synthesis lead to a 
diffuse nontoxic goiter…
• If thyroid function is preserved, most goiters are asymptomatic…
• In substernal goiter, Pemberton’s sign refers to symptoms of faintness with evidence 
of facial congestion and external jugular venous obstruction when the arms are raised 
above the head, a maneuver that draws the thyroid into the thoracic inlet… 
• Respiratory flow measurements and CT or MRI should be used to evaluate substernal 
goiter in patients with obstructive signs or symptoms.
• TFT should be performed in all patients with goiter to exclude thyrotoxicosis or 
hypothyroidism… 
• It is not unusual, particularly in iodine deficiency, to find a low total T4, with 
normal T3 and TSH, reflecting enhanced T4 → T3 conversion… 
• Iodine replacement induces variable regression of goiter in iodine deficiency, 
depending on how long it has been present and the degree of fibrosis that has 
developed. 
• Surgery in diffuse goiter is indicated for documented evidence of tracheal 
compression or obstruction of the thoracic inlet, which are more likely to be 
associated with substernal MNGs…
• Surgery should be followed by replacement with levothyroxine…
• TPO antibodies may  be useful to identify patients at increased risk of autoimmune 
thyroid disease… 
• And low urinary iodine levels (<50 μg/L) support a diagnosis of iodine deficiency…
NONTOXIC MULTINODULAR GOITER
• Depending on the population studied, MNG or nodular enlargement of the thyroid 
occurs in up to 12% of adults and it’s more common in women than men and 
increases in prevalence with age…
• It is more common in iodine-deficient regions but also occurs in regions of iodine 
sufficiency, reflecting multiple genetic, autoimmune, and environmental influences 
on the pathogenesis…
• Using molecular techniques, most nodules within an MNG are polyclonal in origin,
and monoclonal lesions also occur within an MNG, reflecting mutations in genes…
• Histology reveals a spectrum of morphologies ranging from hyper-cellular regions 
to cystic areas filled with colloid and fibrosis is often extensive, and areas of 
hemorrhage or lymphocytic infiltration may be seen…
• Most patients with nontoxic MNG are asymptomatic and euthyroid …
• If the goiter is large enough, it can ultimately lead to compressive symptoms 
including difficulty swallowing, respiratory distress (tracheal compression), or 
plethora (venous congestion), but these symptoms are uncommon. 
• Sudden pain in an MNG is usually caused by hemorrhage into a nodule but 
should raise the possibility of invasive malignancy… 
• Hoarseness, reflecting laryngeal nerve involvement, also suggests malignancy…
• A TSH level should be measured to exclude subclinical hyper- or hypothyroidism, 
but thyroid function is usually normal. 
• Pulmonary function testing can be used to assess the functional effects of 
compression, which characteristically causes inspiratory stridor. 
• CT or MRI can be used to evaluate the anatomy of the goiter and the extent of 
substernal extension or tracheal narrowing.
• The risk of malignancy in MNG is similar to that in solitary nodules…
• Most nontoxic MNGs can be managed conservatively…
• Contrast agents and other iodine-containing substances should be avoided because 
of the risk of inducing the Jod-Basedow effect, characterized by enhanced thyroid 
hormone production by autonomous nodules… 
• T4 suppression is rarely effective for reducing goiter size and introduces the risk of 
subclinical or overt thyrotoxicosis…
• Radioiodine can decrease goiter size and may selectively ablate regions of autonomy
and it’s possible to achieve a 40–50% reduction in goiter size in most patients…
• Surgery remains highly effective but is not without risk, particularly in older 
patients with underlying cardiopulmonary disease…
• Nodular thyroid disease is common, occurring in about 3–7% of adults when 
assessed by physical examination. 
• Using ultrasound, nodules are present in up to 50% of adults, with the majority 
being <1 cm in diameter… 
• Thyroid nodules may be solitary or multiple, and they may be functional or 
nonfunctional.
• A thyroid nodule is a discrete lesion within the thyroid gland that is radiologically 
distinct from the surrounding thyroid parenchyma… 
Thyroid Nodules 
Anatomic scheme of the neck with compartments
• Nodules are more common :
 in iodine-deficient areas, 
 in women, 
 with aging…
• Most palpable nodules are >1 cm in diameter, but the ability to feel a nodule is 
influenced by:
 its location within the gland, 
 the anatomy of the patient’s neck, and 
 the experience of the examiner… 
• Most patients with thyroid nodules have normal thyroid function tests…
• Generally, only nodules >1 cm should be evaluated, since they have a greater 
potential to be clinically significant cancers...
• Occasionally, there may be nodules <1 cm that require evaluation because of :
 suspicious US findings,… 
 associated lymphadenopathy, 
 history of childhood head and neck irradiation,
 history of thyroid cancer in one or more first degree relatives…

• Investigations of thyroid nodules :
 ULTRASONOGRAPHY & other….
 THYROID SCAN
 FNAC
• Most sensitive test to detect lesions in the thyroid and indicated in all patients who 
have a nodular thyroid…
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USG guided FNAC
Indicated if :
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 Palpation-guided FNAC non-diagnostic
 Complex (solid/cystic) nodule
 Impalpable nodule
 Abnormal cervical nodes
Radionuclide Scanning
 Functioning nodules are nearly always benign 
 5 percent of nonfunctioning nodules are malignant …
 Usually either Technetium(Tc99) or Radioiodine(I123) used …
 Both benign and almost all malignant neoplastic tissue concentrate both 
radioisotopes less than normal thyroid tissue…
Cold Nodules
 Cyst
 Non-functioning Adenoma
 Malignancy

• Thyroid nodule diagnostic FNA is recommended for :
 Nodules > 1cm in greatest dimension with high suspicion sonographic pattern 
(Strong recommendation, Moderate-quality evidence)
 Nodules > 1 cm in greatest dimension with intermediate suspicion sonographic 
(Strong recommendation, Low-quality evidence)
 Nodules > 1.5cm in greatest dimension with low suspicion sonographic pattern 
(Weak recommendation, Low-quality evidence) 
 Thyroid nodule diagnostic FNA may be considered for Nodules > 2cm in greatest 
dimension with very low suspicion sonographic pattern (e.g. – spongiform) and 
observation without FNA is also a reasonable option…(Weak recommendation, 
Moderate-quality evidence)

 65% benign, 
 5% malignant or suspicious for malignancy, 
 10% non-diagnostic or yielding insufficient material for diagnosis, and 
 20% indeterminate
In several large studies, FNA biopsies yielded the following findings: 
 The Bethesda System is now 
widely used to provide more 
uniform terminology for 
reporting thyroid nodule FNA 
cytology results...
• A cytology diagnostic for a primary thyroid malignancy will almost always lead to 
thyroid surgery…
primary thyroid malignancy
• If the cytology is reported as suspicious for papillary carcinoma (SUSP), surgical 
management should be similar to that of malignant cytology, depending on clinical 
risk factors, sonographic features, patient preference, and possibly results of 
mutational testing (if performed)… (Strong recommendation, Low-quality evidence)
• After consideration of clinical and sonographic features, mutational testing for BRAF
or the 7-gene mutation marker panel (BRAF, RAS, RET/PTC, PAX8/PPARγ) may be 
considered in nodules with SUSP cytology if such data would be expected to alter 
surgical decision-making (Weak recommendation, Moderate-quality evidence).

• It has been suggested that repeat FNA should be performed no sooner than 3 
months after the initial FNA to prevent false-positive interpretation…
• After a non diagnostic biopsy, if clinical and ultrasound features are suspicious for 
malignancy, a shorter waiting period may be appropriate…
• Repeat FNA with ultrasound guidance will yield a diagnostic cytology specimen in 
60-80% of nodules, particularly when the cystic component is <50% …
• Surgery should be considered for histopathologic diagnosis if :
 Cytological non-diagnostic nodule has a high suspicion sonographic pattern, 
 Growth of the nodule (greater than 20% in two dimensions) during surveillance, 
 Clinical risk factors for malignancy are present…(Low-quality evidence)
Follicular Neoplasm/ Suspicious for Follicular Neoplasm Cytology
• Diagnostic surgical excision is the long-established standard of care for the 
management of follicular neoplasm/suspicious for follicular neoplasm (FN/SFN) 
cytology nodules.
• However, after consideration of clinical and sonographic features, molecular testing 
may be used to supplement malignancy risk assessment data, in lieu of proceeding 
directly with surgery; Informed patient preference and feasibility should be 
considered in clinical decision making. (Weak recommendation, Moderate-quality 
evidence)
• If molecular testing is either not performed or inconclusive, surgical excision may be 
considered for removal and definitive diagnosis of an FN/SFN thyroid nodule…               
(Strong recommendation, Low-quality evidence)
Indeterminate cytology AUS/FLUS Cytology 
• Investigations such as repeat FNA or molecular testing may be used to supplement 
malignancy risk assessment in lieu of proceeding directly with a strategy of either 
surveillance or diagnostic surgery(Weak recommendation, Moderate-quality 
evidence).
• If repeat FNA cytology and/or molecular testing are not performed or inconclusive, 
either surveillance or diagnostic surgical excision may be performed for an 
AUS/FLUS thyroid nodule, depending on clinical risk factors, sonographic pattern, 
and patient preference (Strong recommendation, Low-quality evidence).
• Use of thyroid core-needle biopsy was reported by some to be more informative 
than repeated FNA for sampling nodules that were AUS/FLUS on initial FNA, 
and is reasonably well-tolerated  although morbidity is higher….
• Intraoperative evaluation, with or without frozen section, can occasionally confirm 
malignancy at the time of lobectomy allowing for conversion to total thyroidectomy 
if indicated…
• The individual patient must weigh the relative advantages and disadvantages of 
thyroid lobectomy with possible total thyroidectomy or subsequent completion 
thyroidectomy vs. initial total thyroidectomy….

